The Coca-Cola Company has signed licensing agreement that will let Frutura’d Dayka & Hackett (D&H) use Minute Maid and Simply brands on fresh fruit for the first time.
Products bearing Minute Maid and Simply Select imagery will begin appearing in D&H’s existing brand portfolio at retail in the second quarter of 2023.
Simply Select will initially be used on D&H fresh citrus sold in the US, while the Minute Maid brand will be used on D&H grapes in the US and on D&H fresh citrus and grapes sold in Japan.
D&H is a California-based grower, packer, and distributor of premium fruit.
According to Kayla Carlucci, associate licensing manager with The Coca-Cola Company, the quality of the product that will bear the Coca-Cola name is paramount as is the quality control the licensee exercises at every step along the supply chain.
D&H CEO Tim Dayka, who crafted the licensing agreement on Frutura’s behalf, described the deal as a transformative moment for their company and Frutura, allowing them to increase their market penetration in a meaningful way, as the Minute Maid and Simply brands resonate so strongly with consumers.


Canada’s local food system faces major roadblocks without urgent policy changes
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



